Specific tyrosinases associated with melanoma replicative senescence and melanogenesis.

Replicative senescence occurs in normal cells, in contrast to their malignant counterparts which are generally immortal in vitro. We now show that induction of melanogenesis in subconfluent B16 melanoma cells deprived of growth factors can lead to irreversible growth arrest but continued cell viability, concurrent with the expression of specific glycosylated high molecular weight tyrosinases. These tyrosinase activities identify withdrawal from the cell cycle since they were not detected in reversibly arrested quiescent melanocytes, serum-deprived melanoma, or apoptotic melanoma. Our data suggest that different tyrosinases can distinguish cycling and noncycling cells of melanocytic origin and also imply that replicative senescence can be restored in some tumor cells when induced to terminal differentiation in the absence of growth-promoting agents.

[1]  M. Moore,et al.  Ex vivo differentiation therapy as a method of leukemic cell purging in murine bone marrow expansion cultures. , 1992, Cancer research.

[2]  S. Orlow,et al.  Induction of B16 melanoma melanogenesis by a serum-free synthetic medium. , 1992, Experimental cell research.

[3]  A. Winder,et al.  Induction of tyrosinase in human melanoma cells by L-tyrosine phosphate and cytochalasin D. , 1992, Experimental cell research.

[4]  J. R. Smith,et al.  Common senescent cell‐specific antibody epitopes on fibronectin in species and cells of varied origin , 1992, Journal of cellular physiology.

[5]  I. Jackson,et al.  A second tyrosinase‐related protein, TRP‐2, is a melanogenic enzyme termed DOPAchrome tautomerase. , 1992, The EMBO journal.

[6]  B. Gilchrest,et al.  Pigment content of cultured human melanocytes does not correlate with tyrosinase message level , 1991, The British journal of dermatology.

[7]  A. Kimchi,et al.  Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 , 1991, Nature.

[8]  J. R. Smith,et al.  Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Platts-Mills Tae,et al.  Melanogenesis: a Realistic Target for Antimelanoma Therapy? , 1991 .

[10]  S. Goldstein.  Replicative senescence: the human fibroblast comes of age. , 1990, Science.

[11]  M. Oshimura,et al.  Induction of cellular senescence in immortalized cells by human chromosome 1. , 1990, Science.

[12]  J. Laskin,et al.  Purification of tyrosinase to homogeneity based on its resistance to sodium dodecyl sulfate-proteinase K digestion. , 1989, Archives of biochemistry and biophysics.

[13]  A. Slominski,et al.  MSH inhibits growth in a line of amelanotic hamster melanoma cells and induces increases in cyclic AMP levels and tyrosinase activity without inducing melanogenesis. , 1989, Journal of cell science.

[14]  V. Hearing,et al.  Specific identification of an authentic clone for mammalian tyrosinase. , 1989, The Journal of biological chemistry.

[15]  G. Schütz,et al.  Multiple transcripts of the mouse tyrosinase gene are generated by alternative splicing. , 1988, The EMBO journal.

[16]  D. Bennett,et al.  A line of non‐tumorigenic mouse melanocytes, syngeneic with the B16 melanoma and requiring a tumour promoter for growth , 1987, International journal of cancer.

[17]  I. Weinstein,et al.  Control of melanin synthesis and secretion by B16/C3 melanoma cells , 1982, Journal of cellular physiology.

[18]  J. Pawelek,et al.  New regulators of melanin biosynthesis and the autodestruction of melanoma cells , 1980, Nature.

[19]  E. D. De Robertis,et al.  High tyrosinase activity in albino Xenopus laevis oocytes. , 1976, Journal of embryology and experimental morphology.